Phase I trial of pomalidomide (P) in patients (pts) with relapsed and/or refractory (R/R) Waldenström's macroglobulinemia (WM).
Sheeba K. Thomas
Consultant or Advisory Role - Celgene; Onyx (U); Pharmacyclics
Research Funding - Celgene; Immunomedics; Millennium; Novartis
A. Georgina Melendez
No relevant relationships to disclose
Lei Feng
No relevant relationships to disclose
Michael Wang
Research Funding - Celgene
Sattva Swarup Neelapu
Research Funding - Celgene
Jatin J. Shah
Consultant or Advisory Role - Array BioPharma; Celgene; Millennium; Novartis; Onyx
Research Funding - Array BioPharma; Celgene; Millennium; Novartis; Onyx
Robert Z. Orlowski
Consultant or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Celgene; Millennium; Onyx
Research Funding - Bristol-Myers Squibb; Celgene; Millennium; Onyx; Resverlogix
Donna M. Weber
No relevant relationships to disclose